isomethyleugenol has been researched along with Hamartoma Syndrome, Multiple in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Sohaily, S; Biankin, A; Kohonen-Corish, M; Leong, R; Warusavitarne, J | 1 |
Chang, R; Chang, YW; Chi, SG; Dong, SH; Kim, BH; Kim, HJ; Kim, WK; Kim, YW; Lee, JI; Min, HJ; Park, BJ; Park, JH; Yang, MH | 1 |
1 review(s) available for isomethyleugenol and Hamartoma Syndrome, Multiple
Article | Year |
---|---|
Molecular pathways in colorectal cancer.
Topics: Adenomatous Polyposis Coli; Cell Transformation, Neoplastic; Chromosomal Instability; Colorectal Neoplasms; Colorectal Neoplasms, Hereditary Nonpolyposis; CpG Islands; Hamartoma Syndrome, Multiple; Humans; Methylation; Microsatellite Instability; Peutz-Jeghers Syndrome | 2012 |
1 other study(ies) available for isomethyleugenol and Hamartoma Syndrome, Multiple
Article | Year |
---|---|
Mutational abrogation of the PTEN/MMAC1 gene in gastrointestinal polyps in patients with Cowden disease.
Topics: Adolescent; Adult; Alleles; Female; Gastrointestinal Diseases; Gene Deletion; Gene Expression Regulation; Germ-Line Mutation; Hamartoma Syndrome, Multiple; Humans; Methylation; Mutation; Mutation, Missense; Phosphoric Monoester Hydrolases; Polyps; PTEN Phosphohydrolase; RNA, Messenger; Transcription, Genetic; Tumor Suppressor Proteins | 1998 |